the aid library

LIST OPTIONS

Filter

1990

Emergency Triage Assessment and Treatment (ETAT) Module

National Newborn Health Program (NNHP), Ministry of Health and Family Welfare Bangladesh (2019) CC

Over a period of two decades, under-5 mortality rate in Bangladesh has declined by 66% from 133 per 1000 live births in 1993-94 to 45 per 1000 live births in 2017-18. The country reached the MDG-4 goal in the reduction of child mortality on time. However, the comparison of neonatal and under-5 morta... more

Download (327)

View PDF (436)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021

Kleynhans, J.; et al. (2021) C_CDC

EID Journal , Volume 27, no.12 , Dec. 2021. Early Release Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randoml... more

Download (204)

View PDF (277)

Monkeypox Case Report Form (CRF) (Arabic)

World Health Organization WHO (2022) C_WHO

21 July 2022. The Rapid Core CRF is designed to collect data obtained through examination, interview and review of hospital or clinic notes of patients with suspected, probable, or confirmed monkeypox infection. Data may be collected prospectively or retrospectively. The data collection period is ... more

Download (69)

View PDF (57)

Access to essential respiratory medications remains elusive in LMICs

Karmali, D.; Siddharthan, T. (2022) CC

Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme... more

Download (164)

View PDF (218)

Antibiotic use and resistance in South Africa

Dr T Apalata, Dr C Bamford, Mr D Benjamin et al. South African Medical Journey SAMJ (2011) C2

Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect... more

Download (126)

View PDF (157)

Sécurité des patients-Rendre les soins de santé plus sûrs

Organisation Mondiale de la Santé OMS (2017) C_WHO

La sécurité des patients est un principe fondamental des soins de santé. Plusieurs pays à revenu élevé ont publié des études montrant que les soins de santé causent des préjudices à un grand nombre de patients, et que ces préjudices peuvent entraîner des séquelles durables, des durées... more

Download (165)

View PDF (215)

Gestion de la Pharmacie dans les Centres de Santé au niveau périphérique

Dr Habib Ganfon; Dr Giraud Ekanmian Centre d’Information Pharmacothérapeutique du Bénin (CIP-BENIN) (2017) C2

Le paludisme, appelé également malaria, ou « Mal‘aria », ce qui signifie « mauvais air », est une maladie qui menace 3 milliards de personnes dans 99 pays dans le monde.1 Les personnes les plus vulnérables sont les jeunes enfants et les femmes enceintes, car c’est parmi cette populatio... more

Download (84)

View PDF (77)

The Burden of Pediatric Asthma

Ferrante, G.; La Grutta, S. Frontiers in Pediatrics (2018) CC

Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental fa... more

Download (159)

View PDF (152)

Good Practices in the Rational and Effective Use of Oxygen
recommended

Pan American Health Organisation PAHO PAHO (2021) C_WHO

In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources... more

Download (125)

View PDF (148)

Sentinel surveillance programme for hospitalised individuals with COVID-19 in South Africa

Jassat, W.; et al. (2020) CC

Download (164)

View PDF (170)

Buenas prácticas en el uso racional y efectivo del oxígen

Pan American Health Organisation PAHO (2021) C_WHO

22 Dec 2021: El oxígeno está incluido dentro de la lista de medicamentos esenciales de la OMS y es utilizado para atender pacientes en todos los niveles de las redes integradas de servicios de salud. Dado que la eficacia del uso de oxígeno ya está probada en el tratamiento de pacientes con afecc... more

Download (164)

View PDF (148)

Buenas prácticas en el uso racional y efectivo del oxígeno. Versión preliminar 3.1, diciembre del 2021

Pan American Health Organisation PAHO OPS (2021) C_WHO

El oxígeno está incluido dentro de la lista de medicamentos esenciales de la OMS y es utilizado para atender pacientes en todos los niveles de las redes integradas de servicios de salud. Dado que la eficacia del uso de oxígeno ya está probada en el tratamiento de pacientes con afecciones respira... more

Download (792)

View PDF (1262)

Education and Training. Technical Series on Safer Primary Care

World Health Organization WHO (2016) C_WHO

Good primary care may lead to fewer avoidable hospitalizations, but unsafe primary care can cause avoidable illness and injury, leading to unnecessary hospitalizations, and in some cases, disability and even death.Implementing system changes and practices are crucial to improve safety at all levels ... more

Download (162)

View PDF (150)

Bonnes pratiques pour une utilisation rationnelle et efficace de l’oxygène. Version préliminaire 3.1, décembre 2021

Organización Mundial de la Salud OMS OPS (2021) CC

Avec l’augmentation soudaine du nombre d’hospitalisations causées par la pandémie de COVID-19 en Amérique latine et dans les Caraïbes, et étant donné la rareté des ressources humaines et matérielles telles que les équipements médicaux et les gaz médicaux, il est devenu nécessaire de ... more

Download (108)

View PDF (158)

Boas práticas no uso racional e efetivo do oxigênio. Versão preliminar 3.1, dezembro de 2021

OMS, OPAS OPAS (2021) CC

Em vista do aumento repentino do número de hospitalizações causadas pela pandemia de COVID-19 na América Latina e no Caribe, bem como da escassez de recursos humanos e materiais, como equipes médicas e gases medicinais, é necessário reformular os modelos de atenção na Região de modo a otim... more

Download (299)

View PDF (350)

Rwanda Health Statistics Booklet 2011

Ministry of Health, Rwanda (2012) C2

This booklet provides policymakers, planners, and other interested parties with insight into the current state of the Rwandan health sector. These statistics provide a basis for policies, strategies, and planned interventions to ensure they are responsive to the needs of the health sector and, cruci... more

Download (149)

View PDF (186)

WHO policy brief: COVID-19 testing, 14 September 2022

World Health Organization WHO (2022) C_WHO

The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. It remains critical for national programmes to continue to offer testing for COVI... more

Download (132)

View PDF (201)

Key Considerations for Children and their Caregivers During Covid-19

Govt. Canada; Save the Children; UNICEF (2020) C_UNICEF

The below guidance has been designed to ensure the care of children affected by COVID-19 due to either the child or caregiver requiring medical care in the home, community or health facility, it serves to

Download (254)

View PDF (180)

Vacunación Antigripal 2022 - Guía rapida

Dirección de Control de Enfermedades Inmunoprevenibles Ministerio de Salud Argentina (2022) C2

Vacunación Antigripal 2022 - Guía rapida

Good Practices in the Rational and Effective Use of Oxygen recommended

Good Practices in the Rational and Effective Use of Oxygen
recommended